Anti-proliferative and apoptosis-inducing effects of camptothecin-20(s)-o- (2-pyrazolyl-1)acetic ester in human breast tumor MCF-7 cells

Molecules

Volumn 19, Issue 4, 2014, Pages 4941-4955

  Chu, Chu ^a   Xu, Jialin ^a   Cheng, Dongping ^a   Li, Xingnuo ^a   Tong, Shengqiang ^a   Yan, Jizong ^a   Li, Qingyong ^a,b  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Anti proliferative; Apoptosis; Camptothecin 20(s) O (2 pyrazolyl 1)acetic ester; MCF 7 cell line

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; CAMPTOTHECIN; TOPOTECAN;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL CYCLE; CELL NUCLEUS; CELL SURVIVAL; DNA FRAGMENTATION; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HUMAN; MCF 7 CELL LINE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CALCIUM; CAMPTOTHECIN; CELL CYCLE; CELL NUCLEUS; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; TOPOTECAN;

EID: 84899502550     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19044941     Document Type: Article

References (29)

1. Verschraegen, C.F.; Jaeckle, K. Alternative administration of camptothecin analogues. Ann. N.Y. Acad. Sci. 2000, 922, 237-246.
2. Giovanell, B.C.; Stehlin, J.S. DNA-topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 1989, 246, 1046-1048.
3. Hsiang, Y.H.; Hertzberg, R. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 1985, 260, 14873-14878.
4. Bom, D.; Curran, D.P. The novel silatecan 7-tert-butyldimethylsilyl-10- hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity. J. Med. Chem. 2000, 43, 3970-3980.
5. Van Hattum, A.H.; Pinedo, H.M. New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. Int. J .Cancer. 2000, 88, 260-266.
6. Li, Q.Y.; Zu, Y.G.; Shi, R.Z. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. Bioorg. Med. Chem. 2006, 14, 7175-7182.
7. Li, Q.Y.; Lv, H.Y. Synthesis and antitumor activity of novel 20s-camptothecin analogues. Bioorg. Med. Chem. Lett. 2009, 19, 513-515.
8. Bhutia, S.K.; Mallick, S.K. Abrus abrin derived peptides induce apoptosis by targeting mitochondria in HeLa cells. Cell Biol. International 2009, 33, 720-727.
9. Blagosklonny, M.V.; Pardee, A.B. Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res. 2002, 61, 4301-4305.
10. Giri, B.; Gomes, A. Antiproliferative, cytotoxic and apoptogenic activity of Indian toad (Bufo melanostictus, Schneider) skin extract on U937 and K562 cells. Toxicon 2006. 48, 388-400.
11. Liu, W.; Zhu, Y.S. Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia. Leukemia Res. 2007, 31, 1565-1574.
12. Croce, A.C.; Bottiroli, G. Subcellular localization of the camptothecin analogues, topotecan and gimatecan. Biochem. Pharm. 2004, 67, 1035-1045
13. Stevenson, D.; Wokosin, D. Measurement of the intracellular distribution of reduced glutathione in cultured rat hepatocytes using monochlorobimane and confocallaser scanning microscopy. Toxicol. In Vitro. 2002, 16, 609-619.
14. Jiang, S.G.; Zu, Y.G. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int. J. Oncol. 2008, 33, 103-111.
15. Xiao, X.J.; Huang, G.Q. Morphological study on apoptosis Hela cells induced by soyasaponins. Toxicol. in Vitro 2007, 21, 820-826.
16. Xiao, J.X.; Huang, G.Q. Soyasaponins inhibit the proliferation of Hela cells by inducing apoptosis. Exp. Toxicol. Pathol. 2007, 59, 35-42.
17. Huang, M.; Gao, H.Y. Chimmitecan, a novel 9-substituted Camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin. Cancer Res. 2007, 13, 1298-1307.
18. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
19. Vermeulen, K.; Van Bockstaele, D.R. Apoptosis: Mechanisms and relevance in cancer. Ann. Hematol. 2005, 84, 627-639.
20. Frankfurt, O.S.; Krishan, A. Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs 2003, 14, 555-561.
21. Liu, L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 1989, 58, 351-375.
22. D'Arpa, P.; Beardmore, C. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 1990, 50, 6919-24.
23. Green, D.R. Apoptotic pathways: The roads to run. Cell 1998, 94, 695-698.
24. Kastan, M.B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316-323.
25. Kang, G.Y.; Lee, E.R. Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. Eur. J. Pharmacol. 2009, 611, 17-21.
26. Vermes, I.; Haanen, C. A novel assay for apoptosis, Flow cytometric detection of phosphatidylserin expression on early apoptotic cells using fluorescein labeled annexin-V. J. Immunol. Meth. 1995, 184, 39-51.
27. Fu, Y.R.; Yi, Z.J. Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells and the role of mitochondrial pathway. Mitochondrion 2006, 6, 211-217.
28. Han, J.; Goldstein, L.A. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J. Biol. Chem. 2006, 281, 10153-10163.
29. Yoneyama, K. Validation of confocal laser scanning microscopy for detecting intracellular calcium heterogeneity in live slices. J. Pharmacol. Toxicol. Methods 2001, 45, 187-193.